Butylated Hydroxyanisole vs Propylene Glycol: which is worse?
Quick answer: Butylated Hydroxyanisole carries the heavier risk profile. Butylated Hydroxyanisole is — in the EU and — in the US; Propylene Glycol is — in the EU and — in the US.
| Property | Butylated Hydroxyanisole | Propylene Glycol |
|---|---|---|
| EU status | — | — |
| US status | — | — |
| Risk level | — | — |
| Banned in | Japan (banned for foods containing fats and oils) | — |
| Restricted in | European Union (restricted; banned in baby food), United Kingdom | European Union (not permitted as a direct food additive in most food applications; only permitted as a carrier solvent for specific additives at low levels) |
| Category | additive | additive |
| Where it hides | — | — |
What is Butylated Hydroxyanisole?
Butylated hydroxyanisole (BHA) is a synthetic phenolic antioxidant preservative derived from petroleum (see also bha entry). It is a mixture of 2-BHA and 3-BHA isomers, used to prevent oxidative rancidity in fats, oils, and fat-containing foods. Chemical formula C11H16O2.
What is Propylene Glycol?
Propylene glycol is a synthetic organic compound used as a humectant, solvent, and emulsifier in food, pharmaceuticals, cosmetics, and industrial applications. It is produced from propylene oxide (derived from petroleum). Its chemical formula is C3H8O2.
Documented risks
Butylated Hydroxyanisole: IARC classifies BHA as Group 2B (possible human carcinogen) based on forestomach tumor studies in rodents at high doses. The NTP lists it as 'reasonably anticipated to be a human carcinogen.' EFSA's 2012 review found endocrine-disrupting potential. Japan banned it for food use. The FDA permits it at 0.02% of fat content. Concerns about estrogen-receptor interaction have been documented in animal studies. Contact dermatitis from cosmetic use is reported.
Propylene Glycol: Propylene glycol is generally considered safe by the FDA and is metabolized by the liver to lactic acid and pyruvate (normal metabolites). However, at high doses — particularly from intravenous pharmaceutical formulations — propylene glycol can accumulate and cause lactic acidosis, kidney toxicity, and CNS effects. These effects are seen in critically ill patients receiving high-dose PG-containing intravenous medications, not from food consumption. In children and people with impaired liver or kidney function, PG accumulation may occur at lower doses than in healthy adults. Animal studies have found reproductive and developmental effects at high doses. EFSA's 2018 re-evaluation found no concerns at typical food use levels but noted the EU limits PG use as a direct food additive, using it only as a carrier solvent for permitted additives.
Scan a barcode and we'll flag both Butylated Hydroxyanisole and Propylene Glycol (plus 200+ other ingredients banned overseas).
Scan free →